S Rajagopalan Selected Research

S Rajagopalan Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 08/2007
3	Inflammation (Inflammations) 05/2016 - 12/2001
3	Infections 07/2012 - 10/2000
2	Neoplasms (Cancer) 09/2019 - 02/2009
2	Type 2 Diabetes Mellitus (MODY) 05/2016 - 02/2012
2	Atherosclerosis 04/2014 - 06/2001
2	Wounds and Injuries (Trauma) 04/2013 - 05/2012
2	Tuberculosis (Tuberculoses) 10/2001 - 09/2000
2	Drug-Related Side Effects and Adverse Reactions 10/2001 - 10/2000
1	Pheochromocytoma 09/2019
1	Urinary Tract Infections (Urinary Tract Infection) 08/2017
1	Cellulitis 10/2016
1	Alcoholic Fatty Liver 05/2016
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 09/2015
1	Poisoning 07/2014
1	Esophageal Perforation 07/2014
1	Burns 04/2013
1	Fever (Fevers) 04/2013
1	Pain (Aches) 04/2013
1	Abscess 07/2012
1	Anemia 11/2011
1	Keratomalacia 09/2009
1	Carcinogenesis 02/2009
1	Genomic Instability 02/2009
1	Shock 11/2008
1	Ischemia 10/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007
1	Abdominal Aortic Aneurysm 10/2007
1	Vascular Calcification 08/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2006
1	Thrombosis (Thrombus) 01/2006
1	Overweight 12/2001
1	Hyperlipidemias (Hyperlipidemia) 12/2001
1	Ventricular Fibrillation 11/2001
1	Parkinson Disease (Parkinson's Disease) 09/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2001
1	Peripheral Arterial Disease 08/2001
1	Hypertension (High Blood Pressure) 06/2001
1	Heart Failure 06/2001
1	Communicable Diseases (Infectious Diseases) 01/2001
1	Chronic Disease (Chronic Diseases) 10/2000

Drug/Important Bio-Agent (IBA)

2	Particulate MatterIBA 10/2023 - 10/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2012 - 01/2001
2	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2011 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 02/2009 - 09/2001
1	CatecholaminesIBA 09/2019
1	Recombinases (Recombinase)IBA 08/2017
1	MercuryIBA 10/2016
1	Phosphodiesterase 4 InhibitorsIBA 05/2016
1	Glucose (Dextrose)FDA LinkGeneric 05/2016
1	SteroidsIBA 09/2015
1	Immunoglobulins (Immunoglobulin)IBA 09/2015
1	Glyphosate (Roundup)IBA 07/2014
1	MicroRNAs (MicroRNA)IBA 04/2014
1	aliskiren FDA Link 04/2014
1	ReninIBA 04/2014
1	Urea (Carbamide)FDA LinkGeneric 04/2013
1	PapainIBA 04/2013
1	Sulfadiazine (Sulphadiazine)FDA Link 04/2013
1	SilverIBA 04/2013
1	NitroimidazolesIBA 07/2012
1	Platelet-Derived Growth FactorIBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Thioctic Acid (Lipoic Acid)IBA 11/2011
1	MineralsIBA 11/2011
1	omega-Chloroacetophenone (Mace)IBA 05/2011
1	ZincIBA 09/2009
1	IronIBA 09/2009
1	DNA HelicasesIBA 02/2009
1	Carrier Proteins (Binding Protein)IBA 02/2009
1	AnionsIBA 11/2008
1	SolutionsIBA 11/2008
1	Adenosine Diphosphate (ADP)IBA 10/2007
1	thrombin receptor peptide SFLLRNPIBA 10/2007
1	Fibrinogen (Factor I)FDA Link 10/2007
1	Arachidonic Acid (Vitamin F)IBA 10/2007
1	P-SelectinIBA 10/2007
1	CytokinesIBA 08/2006
1	CalciumIBA 08/2006
1	AldosteroneIBA 01/2006
1	Lipoproteins (Lipoprotein)IBA 12/2001
1	C-Reactive ProteinIBA 12/2001
1	oxidized low density lipoproteinIBA 12/2001
1	alpha-SynucleinIBA 09/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2001
1	Mineralocorticoid Receptor AntagonistsIBA 06/2001
1	MineralocorticoidsIBA 06/2001
1	Tuberculin (PPD)IBA 10/2000

Therapy/Procedure

3	Therapeutics 09/2015 - 10/2000
2	Vascular Surgical Procedures 05/2011 - 10/2007
1	Aftercare (After-Treatment) 04/2014
1	Debridement 04/2013
1	Time-to-Treatment 02/2012
1	Synchrotrons 11/2008
1	Extracorporeal Membrane Oxygenation 11/2001
1	Institutionalization (Institutionalized Persons) 10/2001
1	Nutritional Support (Artificial Feeding) 10/2000
1	Polypharmacy 10/2000
1	Long-Term Care 09/2000